Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arcturus Therapeutics Ltd (NASDAQ:ARCT)

8.50
Delayed Data
As of 3:57pm ET
 -0.40 / -4.49%
Today’s Change
5.81
Today|||52-Week Range
18.04
-42.18%
Year-to-Date
No recent news for Arcturus Therapeutics Ltd.

Today’s Trading

Previous close8.90
Today’s open8.83
Day’s range8.33 - 8.83
Volume19,116
Average volume (3 months)121,117
Market cap$35.0M
Data as of 3:57pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)+1.11%
Earnings growth (this year)+70.47%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.19

Competitors

 Today’s
change
Today’s
% change
ITEKInotek Pharmaceutica...+0.13+5.63%
TNXPTonix Pharmaceutical...+0.03+0.81%
VICLVical Inc-0.05-2.73%
EBIOEleven Biotherapeuti...+0.01+1.46%
Data as of 4:12pm ET, 12/14/2017

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$0.00
Annual profit (last year)-$24.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Joseph E. Payne
COO, Director &
Chief Scientific Officer
Padmanabh Chivukula
Corporate headquarters
San Diego, California

Forecasts